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The open reading frame EP153R of African swine fever virus (ASFV) encodes a nonessential protein that has been involved in the
hemadsorption process induced in virus-infected cells. By the use of a virus deletion mutant lacking the EP153R gene, we have detected, in
several virus-sensitive cells, increased levels of caspase-3 and cell death as compared with those obtained after infection with the parental
BA71V strain. Both transient and stable expression of the EP153R gene in Vero or COS cells resulted in a partial protection of the transfected
lines from the apoptosis induced in response to virus infection or external stimuli. The presence of gene EP153R resulted in a reduction of the
transactivating activity of the cellular protein p53 in Vero cell cultures in which apoptosis was induced by virus infection or staurosporine
treatment. This is to our knowledge the first description of a viral C-type lectin with anti-apoptotic properties.
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C-type animal lectins are proteins found in serum,
extracellular matrix, and cellular membranes, which exhibit
a Ca2+-dependent carbohydrate-binding activity enabling
the recognition of both endogenous and exogenous specific
glycoconjugates in animals. Lectins are generally consid-
ered as non-enzymatic proteins acting as receptors for
carbohydrate ligands (Gabius, 1997). It is known, on the
other hand, that several cells of the immune system (macro-
phages, B, T, and natural killer cells) display receptors with
sequence similarity to C-type lectins, thus involving the
mammalian lectins both in cell-to-cell interactions and in
pathogen recognition by their ability to mediate discrimina-
tion between self and nonself (Weis et al., 1998). Several
proteins with C-type lectin-like domains have been reported0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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(fowlpox (Afonso et al., 2000; Tomley et al., 1988),
vaccinia (Blasco et al., 1993; Goebel et al., 1990; Wilcock
et al., 1999), cowpox (Shchelkunov et al., 1998), myxoma
(Cameron et al., 1999), and molluscum contagiosum (Sen-
kevich et al., 1996)), although a lectin homologue has also
been found in herpesviridae (cytomegalovirus (Voigt et al.,
2001)) and in asfarviridae (African swine fever virus
(ASFV) (Galindo et al., 2000; Neilan et al., 1999; Ya´n˜ez
et al., 1995)). These proteins have proven or putative roles
in virus infectivity, cell to cell spreading, inhibition of cell-
mediated cytotoxicity, or hemadsorption. However, the
actual function of many of the viral lectin homologues in
immune evasion or in the virus infective cycle remains to be
determined.
In addition to the immune response developed by the
host to combat virus infections, the infected cell itself can
activate a suicide program (O’Brien, 1998), which may
have an adverse effect on virus replication. In turn, viruses
have evolved different strategies to regulate this process,
C. Hurtado et al. / Virology 326 (2004) 160–170 161either by preventing premature cell death to allow infec-
tious virus production or by promoting apoptosis for rapid
cell-to-cell virus dissemination (Everett and McFadden,
1999).
African swine fever virus (ASFV), a large enveloped
deoxyvirus, is the causative agent of a highly contagious
disease of domestic pigs and infects a variety of cells of
the mononuclear phagocytic system (reviewed in (Costa,
1990; Hess, 1981; Vinuela, 1985). ASFV replication can
elicit the apoptotic response both in acute in vivo
(Gomez-Villamandos et al., 1995; Oura et al., 1998;
Ramiro-Ibanez et al., 1996) and in vitro infections (Nogal
et al., 2001), in a process triggered in the absence of
virus replication, after virus internalization, and before
early virus protein synthesis, most probably during the
virus uncoating (Carrascosa et al., 2002). Several ASFV
genes have been reported to modulate the programmed
cell death or to interfere with the host cell response;
among them, A179L, which encodes a viral Bcl-2 homo-
logue (Afonso et al., 1996; Revilla et al., 1997), and
A224L, with similarity to IAP genes (Chacon et al., 1995;
Nogal et al., 2001), have been shown to inhibit caspase
activation and promote cell survival in mammalian cells.
A224L is also able to activate the transcription factor NF-
nB (Rodriguez et al., 2002), while another ASFV gene,
A238L, which encodes an IkappaB-like protein (Powell et
al., 1996; Revilla et al., 1998), behaves as an effective
inhibitor of NF-nB activity (Revilla et al., 1998). As
mentioned above, the ASFV genome also contains a gene
(EP153R) with a C-type animal lectin-like domain (Ya´n˜ez
et al., 1995), which has been involved in the hemadsorp-
tion process observed in ASFV-infected cells (Galindo et
al., 2000). The EP153R gene is transcribed both during
the early and late phases of the infectious cycle, the
expression of the protein pEP153R being detected from
early times (6 hpi) after infection. Besides the C-type
lectin domain, the EP153R sequence reveals a cell at-
tachment (RGD) sequence and significant homology with
the N-terminal region of CD44 molecules involved in
cellular adhesion and T-cell activation, respectively. We
show in this report that the ASFV protein pEP153R has
an inhibitory effect on the caspase-3 activation and the
apoptosis induced both in ASFV-infected cells and in cell
lines transfected, either stably or transiently, with the
EP153R gene and treated with different pro-apoptotic
stimuli. To our knowledge, this is the first description
of a viral C-type lectin with anti-apoptotic properties.Results
EP153R inhibits caspase-3 activity and cell death during
ASFV infection
We have previously shown that permissive Vero cells
develop apoptosis, as characterized by DNA fragmenta-tion, caspase activation, cytosolic release of mitochondri-
al cytochrome c, and flow cytometric analysis of DNA
content, upon infection with ASFV (Carrascosa et al.,
2002). Proteolysis of caspase-3 from its 32-kDa precur-
sor to the active form (17 kDa) was used in this study
to quantify the apoptosis induced in Vero cells infected
with either the parental strain BA71V or the EP153R
deletion mutant (DEP153R). As shown in Figs. 1A and
B and as previously reported, caspase-3 activation was
first detected in virus-infected cells at 12 hpi, increasing
until 20–25 hpi. It can also be noticed that cultures
infected with DEP153R exhibited higher amounts of the
17-kDa band, indicating that the processing of procas-
pase-3 to its active form was enhanced in the absence of
EP153R gene expression. As can be seen in Fig. 1C, the
results of caspase-3 cleavage correlated perfectly well
with the analysis of enzymatic activity. To confirm that
the increase in caspase-3 activity was associated with
programmed cell death, the cell cycle of virus-infected
cultures was analyzed by flow cytometry after PI stain-
ing (Fig. 1D). As expected, the percentages of cell death
were always higher from 12 hpi in cells infected with
DEP153R than in BA71V-infected cultures. To provide a
more statistical value of the increase in caspase-3 asso-
ciated to the absence of EP153R, we have calculated in
28 independent determinations (including assays of bio-
logical activity and quantification of the17-kDa protein
by several methods) the ratio between the level of
caspase-3 in DEP153R-infected and BA71V-infected cul-
tures, analyzed at late times of infection (15–30 hpi),
resulting in a factor of 2.11 F 0.58. From these results,
we conclude that the absence of gene EP153R in the
ASFV infection increases about 2-fold the activity of
caspase-3.
Because other caspases have been shown to play a
key role in apoptosis, we have studied the effect of
EP153R expression on the enzymatic activity of cas-
pases 6 and 8 in Vero cells infected with either
BA71V or DEP153R virus isolates (Fig. 2A). The
activity of caspases 6 and 8 was only slightly in-
creased in BA71V-infected Vero cells, and this increase
was not affected by the absence of the EP153R gene
in cells infected with the mutant DEP153R virus.
These findings also indicate the predominant role for
caspase-3 (increased up to 7-fold) in the apoptosis in-
duced by ASFV, as previously described (Nogal et al.,
2001).
To rule out the possibility that the expression of the
LacZ gene, inserted under the control of ASFV promoter
p72 into the EP153R locus for the construction of
DEP153R deletion mutant (Galindo et al., 2000), could
be responsible for the enhanced caspase-3 activation
observed in DEP153R-infected cells, we performed the
analysis presented in Fig. 2B: Vero cells were infected
with ASFV isolates containing either a h-galactosidase
(DEP153R and vDCD2) or a h-glucuronidase (v72GUS)
Fig. 1. Analysis of apoptosis in ASFV-infected Vero cells. Cultures were mock-infected or infected with BA71V or DEP153R at a moi of 3 pfu/cell and
collected at the times indicated to determine the activation of caspase-3 by detection of the 17-kDa fragment in Western blots (A and B) or biological activity
(C), and the percentage of cell death by flow cytometry after PI staining (D). The control of protein loading was performed with anti-actin antibodies and is
shown in panel A. The quantification (mean F SD) of the 17-kDa fragment from two separate experiments is shown in panel B. The values were corrected
taking into account the actin content in each sample. Data on caspase-3 biological activity (panel C) and cell death (panel D) are also the average (FSD) of
duplicate samples.
C. Hurtado et al. / Virology 326 (2004) 160–170162gene, and analyzed for caspase-3 cleavage by immuno-
blotting, as described above. Proteolytic cleavage was
only enhanced in cells infected with DEP153R, indicat-ing that the observed effect is due to the absence of gene
EP153R, and not to the insertion of a foreign gene (lacZ
or gusA) into the ASFV genome.
Fig. 2. Caspase activation in ASFV-infected Vero cells. (A) Cultures were infected with BA71Vor DEP153R at a moi of 3 pfu/cell and collected at the indicated
times to determine the protease activity of caspases on specific substrates (Ac-DVED-AMC, Ac-VEID-AMC, and Ac-IETD-AMC for caspase -3, -6, and -8,
respectively) after normalizing the cell extracts for total protein content (1 mg/ml). Data represent caspase activities relative to the values at zero time of
infection with BA71V for each protease. (B) Vero cells were mock-infected or infected with ASFV isolates containing or not either a h-galactosidase
(DEP153R and vDCD2) or a h-glucuronidase (v72GUS) gene, and analyzed for caspase-3 cleavage by immunoblotting, as indicated in the legend to Fig. 1.
The quantification (mean F SD) of the 17-kDa fragment from triplicate samples is shown below.
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ASFV-induced apoptosis
To further analyze the role of gene EP153R, we studied
the effect of its absence in infections performed in three
ASFV-sensitive cell lines. Cultures of Vero, COS, and BHK
cells were infected with either the parental strain BA71V or
DEP153R and analyzed for their DNA content by flow
cytometry at 20 hpi. As shown in Fig. 3A, the percentage of
cell death was always higher in each particular cell line
when infected with the EP153R deletion mutant. To deter-
mine more precisely the apoptotic response in swine macro-
phages, the natural target cell for ASFV, we analyzed the
biological activity of caspase-3 and the percentage of cell
death along the infective cycle in cultures infected either
with BA71V or DEP153R (Figs. 3B and C). From these
results, we could establish that (i) the onset of apoptosis
occurred earlier in infected swine macrophages than in
infected Vero cells, (ii) in the interval of 8–15 hpi, macro-
phages infected with DEP153R displayed higher levels of
apoptotic response than those of BA71V-infected cultures,
and (iii) at later times of infection (from 20 hpi), the values
obtained from both infections tend to equalize.
Taken together, these results supported the conclusion
that the absence of EP153R expression resulted in an
enhancement of the apoptotic response developed in virus-
sensitive infected cells.
Transient or stable transfection of EP153R gene results in
protection from drug or virus-induced apoptosis
To confirm the role of EP153R in the control of apopto-
sis, we performed a series of experiments to analyze theeffect of EP153R expression in heterologous systems. After
subcloning the ASFV EP153R gene into the pcDNA3.1
mammalian expression vector, the plasmids were trans-
fected for transient or stable expression into Vero and
COS cells as described under Materials and methods. Stably
transfected cell lines displayed growing kinetics and satu-
ration densities similar to their original cell types, indicating
that the transfection process had no deleterious effect on
them. The analysis of EP153R mRNA expression by RT-
PCR (Fig. 4A) revealed the presence of EP153R-specific
transcripts in cell cultures transfected for transient or stable
expression with the EP153R-containing vector and their
absence in the corresponding controls transfected with the
plasmid alone. To analyze the effect of EP153R gene in
heterologous expression, transiently transfected Vero cell
cultures were treated, 24 h after transfection, with different
apoptotic drugs (2 Ag/ml actinomycin D, 1 AM staurospor-
ine, or 4 AM camptothecin) and further incubated for 24 h.
Cell extracts were prepared and assayed for biological
activity of caspase-3. As shown in Fig. 4B, all of the drugs
were able to induce an approximately 5-fold activation of
caspase-3 in control pcDNA-transfected Vero cell cultures,
while little or no induction was detected in EP153R-trans-
fected cells, revealing a considerable protection from apo-
ptosis in Vero cells transiently expressing the EP153R gene.
As we had previously determined that one of the best
apoptosis inducers in virus-sensitive cells was precisely
the ASFV infection, we used the deletion mutant DEP153R
EP153R virus to provoke the apoptotic process and then
analyzed the possible protective effect of EP153R expres-
sion in COS cells stably transfected with control or
EP153R-containing pcDNA (Fig. 4C), as described above.
As expected, ASFV infection was able to induce a level of
Fig. 3. Analysis of cell cycle and caspase-3 activity in ASFV-sensitive cell lines infected with BA71Vor DEP153R isolates. Cultures of Vero, COS, and BHK
cells were mock-infected or infected with BA71Vor DEP153R at a moi of 3 pfu/cell and subjected at 20 hpi to cell cycle analysis by flow cytometry after PI
staining (panel A). The percentage of total cell death (M1 value) is indicated at the left side of each graph. Cultures of swine macrophages were infected in
parallel and processed at the indicated times to determine the biological activity of caspase-3 (panel B) or the percentage of cell death by flow cytometry
(panel C).
C. Hurtado et al. / Virology 326 (2004) 160–170164caspase-3 activity much higher than pro-apoptotic drugs
(compare ordinates in panels B and C of Fig. 4), and a
partial protection (up to approximately 45%) from virus-
induced caspase-3 activation was observed in EP153R-
transfected COS cells at 24 hpi, indicating again a protective
role for EP153R gene in ASFV-induced apoptosis. These
results were confirmed in stably transfected Vero cells,
which were analyzed by determination of the percentage
of cells undergoing early apoptosis (stained by Annexin V)
(Fig. 4D), after mock-infection or infection with DEP153R
virus. The Annexin V apoptotic indicator corroborated that
the expression of gene EP153R in Vero cells conferred
resistance to the ASFV-induced programmed cell death.
Effect of EP153R gene on p53 activity
In an effort to elucidate the mechanism by which the viral
EP153R gene inhibits the apoptotic process, we searched for
possible differences in the expression or intracellular distri-bution of protein p53, a cellular component involved both in
the apoptotic cascade and in cell cycle control, in Vero cells
infected with BA71V or DEP153R. Previous experiments
from our laboratory had shown a clear induction of p53 in
ASFV-infected cultures (Granja et al., in press). The exam-
ination of Vero cell cultures infected with BA71V or
DEP153R by confocal microscopy, using a specific anti-
p53 antibody (Fig. 5A), showed a nuclear localization for
the ASFV-induced p53, which accumulated in this compart-
ment throughout the virus cycle until 20 hpi. However, no
relevant differences could be detected in the distribution or
level of expression of p53 associated to the presence
(BA71V) or absence (DEP153R) of gene EP153R. To
analyze whether the action of EP153R could interfere with
the biological activity of p53, we studied the p53-trans-
activating activity induced in pcDNA- or EP153R-stably
transfected Vero cells at 15 h after staurosporine treatment.
A slight (about 20%), but consistent, reduction of p53-
transactivating activity was obtained in cells transfected
Fig. 4. EP153R mRNA expression, caspase-3 activity, and Annexin V
staining in transiently or stably EP153R-transfected Vero and COS cells.
(A) Cultures of Vero or COS cells, transiently (T) or stably (S) transfected
with pcDNA3.1 (pc) or pcDNA3.1-EP153R (EP) plasmids, were collected
for RT-PCR analysis. Total RNA was reverse-transcribed to cDNA and
PCR-amplified with primers specific for EP153R viral gene before being
analyzed by agarose gel electrophoresis. (B) Vero cell cultures were
transfected with 2 Ag of pcDNA3.1 or pcDNA3.1-EP153R plasmids and,
24 h later, the cultures were treated with pro-apoptotic drugs (2 Ag/ml
actinomycin D, 1 AM staurosporine, or 4 AM camptothecin). The biological
activity of caspase-3 was determined in triplicate samples collected
24 h after drug treatment. (C) Cultures of stably transfected COS cells
were infected with DEP153R at a moi of 3 pfu/cell and collected at 20 hpi
to analyze the biological activity of caspase-3 in triplicate samples. (D)
Cultures of stably transfected Vero cells were mock-infected or infected
with DEP153R at a moi of 3 pfu/cell and collected at 20 hpi to analyze the
percentage of apoptotic cells (Annexin V positives) in triplicate samples.
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EP153R might reduce to some extent the response of cells to
external injuries. To confirm this effect, we made the same
analysis in stably transfected Vero cells after 18 h of
infection with BA71V as genotoxic inducer: a reduction of
approximately 75% in p53 activity was observed in cells
transfected with the viral gene (Fig. 5C). From these results,
it should be inferred that a possible role of EP153R would
be the inhibition of p53 function in ASFV-infected cells;
accordingly, when p53 activity was assayed in Vero cellsinfected either with BA71V or DEP153R virus isolates, a
higher activity was observed in cultures infected with the
EP153R-defective virus (Fig. 5D). The fact that EP153R
was less efficient in inhibiting the p53 activity induced by
staurosporine (Fig. 5B) than that induced by ASFV infection
(Figs. 5C and D) indicates that the mode of triggering the
p53 response is important to determine its chances to be
inhibited.Discussion
The recognition of a broad repertoire of carbohydrate
specificities in cell surfaces by lectins has important impli-
cations in many biological processes. The binding of mito-
genic lectins to glycoproteins expressed on the plasma
membrane of T-cells results in the stimulation of lympho-
cytes as well as other cells (Ashraf and Khan, 2003),
although the induction of apoptosis by Concanavalin A in
cultured murine macrophages has also been reported (Suen
et al., 2000). In the case of C-type animal lectins, their main
roles are derived from its activity as membrane-bound
receptors that mediate recognition or endocytosis of glyco-
proteins (Drickamer and Taylor, 1993). The involvement of
C-type lectins in the modulation of apoptosis has been
recently proposed in the case of human HIP/PAP C-type
lectin encoding gene, which stimulates liver regeneration
and protects hepatocytes against TNF-alpha plus actinomy-
cin-D-induced apoptosis (Simon et al., 2003), and for CD94/
NKG2 murine NK cell receptors, whose expression is also
correlated with a lower level of apoptosis (Gunturi et al.,
2003), but has never been described in C-type lectin genes
encoded by animal viruses. Members of the poxviridae
(Afonso et al., 2000; Blasco et al., 1993; Cameron et al.,
1999; Goebel et al., 1990; Senkevich et al., 1996; Shchel-
kunov et al., 1998; Tomley et al., 1988; Wilcock et al.,
1999), herpesviridae (Voigt et al., 2001), and asfarviridae
(Galindo et al., 2000; Neilan et al., 1999; Ya´n˜ez et al., 1995)
families have been reported to encode proteins with C-type
lectin-like domains, with activities modulating virus infec-
tivity, cell to cell spreading, or hemadsorption.
In the case of the ASFV gene EP153R, which has been
involved in the hemadsorption process observed in ASFV-
infected cells (Galindo et al., 2000), the sequence of the
BA71V strain revealed, besides the C-type lectin domain
and the homology with the N-terminal region of CD44
molecules, the presence of a cell attachment (RGD) se-
quence (Ya´n˜ez et al., 1995) that could be involved in the
modulation of apoptosis by direct caspase-3 activation, as
reported for RGD peptides (Buckley et al., 1999). Conse-
quently, we have analyzed in this work the effect of gene
EP153R on the apoptosis induced in ASFV-sensitive Vero
cells infected either with the parental virus BA71V or with
the deletion mutant virus DEP153R that lacks the EP153R
gene. Our results clearly show an enhanced activation of
caspase-3 (determined either by processing of procaspase-3
Fig. 5. (A) Subcellular localization of ASFV-induced p53. Vero cell cultures were mock-infected or infected with BA71V or DEP153R isolates at a moi of
3 pfu/cell. At the times indicated, cultures were labeled with anti-p53 antibody and then examined by confocal microscopy. (B and C) p53 transactivating
activity in pcDNA or EP153R stably transfected Vero cells. Cultures of stably transfected Vero cells were transfected with p53RE-luc plasmid (100 ng per 106
cells) and incubated for 24 h before the addition of 1 AM staurosporine (panel B) or infection with BA71V at a moi of 3 pfu/cell (panel C). Cell extracts
prepared after 15 h of staurosporine treatment or after 18 h of virus infection were analyzed for p53-transactivating activity. Data in panel B are the mean F SD
of duplicate samples and correspond to one of three independent experiments. Panel C shows the average values of luciferase activity and standard deviations
from five independent experiments (with, at least, triplicate samples). (D) p53 transactivating activity in ASFV-infected Vero cells. Cultures were transfected
with p53RE-luc plasmid (as in B and C) 24 h before infection with BA71Vor DEP153R virus isolates at a moi of 3 pfu/cell. At 22 hpi, p53 activity was assayed
in triplicate samples. Data correspond to the average values of luciferase activity and standard deviations from two independent experiments.
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resulted in an increase in the percentage of cell death, in
Vero cell cultures infected with DEP153R as compared to
those infected with the parental BA71V isolate. This was the
opposite effect to that expected if the RGD sequence present
into gene EP153R would activate caspase-3 (as reported for
soluble RGD peptides), which should inhibit the apoptosis
in cells infected with the deletion mutant DEP153R. Thus,
the anti-apoptotic action of gene EP153R must not be
related to the RGD sequence, but to another part of the
molecule. Interestingly, the analysis of caspase-3 activation
in swine macrophages at different times after infection with
BA71Vor DEP153R revealed that ASFV gene EP153R was
also able to modulate the apoptotic process in the natural
target cell for ASFV in a similar manner to that observed in
other ASFV-sensitive cell lines (Vero, COS, and BHK).
To further confirm themodulation of apoptosis assigned to
the viral protein, we have tested the effect of the expression of
EP153R in a heterologous system by stable or transient
transfection of the ASFV gene into Vero or COS cells. Using
this protocol, we were also able to associate the presence ofEP153R with a protective effect from the apoptosis triggered
in cell cultures by chemical inducers (actinomycin D, staur-
osporine, or camptothecin) or by ASFV infection. Taken
together, these results demonstrate a role in the control of
apoptosis for ASFV gene EP153R.
Regarding the mechanism by which EP153R accom-
plishes the inhibition of apoptosis, we investigated for
possible differences in the expression of several components
involved in the apoptotic induction pathway, upstream the
activation of effector caspase-3, in cells infected with
BA71Vor DEP153R. No relevant differences were observed
by immunoblotting studies revealed with antibodies specific
against p53, p21, Mdm2, Bcl-2, and Bax (data not shown).
However, we could determine that the presence of gene
EP153R in stably transfected Vero cells resulted in a
reduced ability to induce p53 transactivating activity after
staurosporine treatment or ASFV infection. The analysis by
confocal microscopy of the expression and distribution of
p53 in Vero cells infected with BA71V or DEP153R
revealed that p53 was equally induced and accumulated
into the nucleus in both infections. However, the trans-
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infected with the deletion mutant virus DEP153R, suggest-
ing that EP153R might be involved in the control of p53
activity rather than in its expression or distribution. It must
be noted that the activation of p53 can be modulated at three
levels: increase of p53 expression, transformation of the
protein from a latent to an active conformation through
phosphorylation or acetylation, and translocation of p53 to
the nucleus, where it acts as a transcriptional factor (Prives
and Hall, 1999; Qian et al., 2002). In the case of ASFV
infection, it seems that translocation of p53 to the nucleus
occurs at early times of infection (Granja et al., in press) and
that activation of p53 as a transcriptional factor is partially
inhibited by the presence of EP153R. The possible connec-
tion between the inhibition of p53 activity and the protection
from apoptosis by EP153R in ASFV-infected cells is still
speculative. Further experiments are needed to determine
the effect of gene EP153R in p53 posttranslational mod-
ifications and in successive steps downstream of p53 acti-
vation to elucidate the involvement of the viral gene in the
control of cell cycle and death. The presence of a double
lysine motif (preserved in many ASFV isolates, Neilan et
al., 1999) within the cytoplasmic (C-terminal) tail of
pEP153R, a characteristic shared with several proteins from
human, rat, hamster, and viral (human adenovirus) origin
that reside in the endoplasmic reticulum (Jackson et al.,
1990), may target pEP153R to this subcellular compart-
ment, which might exclude the viral protein from direct
interaction with caspase-3, but should allow it to produce
some disturbance in interactions between resident elements
or in the Ca+ metabolism in the reticulum, resulting in the
alteration by inhibition of the apoptotic process.
In conclusion, we report here that the ASFV gene
EP153R behaves as an inhibitor of the apoptosis induced
by the virus in infected cells. It is interesting to note that
there are at least two other ASFV genes involved in the
inhibition of apoptosis: A179L, which encodes a viral Bcl-2
homologue (Afonso et al., 1996; Revilla et al., 1997) and
A224L, with similarity to IAP genes (Chacon et al., 1995;
Nogal et al., 2001), which inhibit caspase activation and
promote cell survival in mammalian cells. The reason why
ASFV carries such an anti-apoptotic battery of genes is
unknown, but it is tempting to speculate that, because the
programmed cell death is a process triggered at early times
and developed at intermediate and late times after ASFV
infection (Carrascosa et al., 2002), it must be controlled
from the virus uncoating process and throughout the infec-
tive cycle to prolong cell survival and maximize the
production of viral progeny. This could account for the
presence of anti-apoptotic genes transcribed either late
(A224L) after virus infection or at both early and late
(A179L and EP153R) times of infection and for the pres-
ence of anti-apoptotic proteins in the viral particle (A224L),
which might confer protection from apoptosis induced
during virus internalization, transcription, replication, or in
any other step in the infectious cycle. Besides the differenttimes of expression, the existence of several anti-apoptotic
genes should confer other advantages to the virus, such as
the increase of the response against cell suicide by the sum
of activities, the development of resistance to the apoptosis
induced by the cytolytic action of natural killer cells and
cytolytic T lymphocytes, or the interference with different
routes of apoptosis induction: in the case of ASFV, genes
A179L (Bcl-2), A224L (IAP), and EP153R (C-type lectin)
might interfere with the induction of the mitochondrial
pathway, the efficiency of effector caspase-3, and the
activation of p53, respectively. In any case, it becomes
evident that ASFV is especially concerned about the control
of apoptosis in the infected host cell. Additionally, it must
be considered that ASFV encodes proteins with the capacity
to regulate the transcription machinery of the host cell, like
A224L, reported to activate the NF-nB activity (Rodriguez
et al., 2002), and A238L (Powell et al., 1996; Revilla et al.,
1998), which encodes an IkappaB-like molecule that pre-
vents the activation of both NF-nB and NFAT transcription
factors (Miskin et al., 1998; Miskin et al., 2000; Revilla et
al., 1998; Tait et al., 2000), extending even more the
capacity of ASFV to interfere with the expression of cellular
genes involved in the activation of immune response,
inflammation, and lastly in the control of cell viability.Materials and methods
Cells and viruses
The established cell lines used in this report were seeded
fromworking stocks kept in store in our laboratory and can be
obtained from the American Type Culture Collection. Swine
alveolar macrophages were prepared by bronchoalveolar
lavage as previously described (Carrascosa et al., 1982). Cells
were cultured at 37 jC in Dulbecco’s modified Eagle (DME)
medium supplemented with either 5% newborn calf serum
(Vero), 5% heat-inactivated fetal calf serum (COS and BHK),
or 10% homologous swine serum (swine macrophages).
The Vero-adapted ASFV strain BA71V was propagated
and titrated by plaque assay on Vero cells as described
(Carrascosa et al., 1982; Enjuanes et al., 1976). The con-
struction and evaluation of the ASFV deletion mutant lacking
gene EP153R (DEP153R) have been previously reported
(Galindo et al., 2000). The ASFV recombinants vDCD2,
lacking the virus CD2 homologue, and v72GUS, with the
gusA gene under the control of the viral p72.4 promoter
inserted into the thymidine kinase locus, have been described
before (Garcia et al., 1995; Rodriguez et al., 1993).
Transfections
The viral EP153R gene was subcloned into the
pcDNA3.1 mammalian expression vector (Invitrogen). For
transient expression, Vero or COS cells were plated at 1 
106 per 6 cm dish 24 h before being transfected with 2 Ag of
C. Hurtado et al. / Virology 326 (2004) 160–170168pcDNA3.1 or pcDNA3.1-EP153R using 12 Al of Lipofect-
amine (2 mg/ml, Invitrogen) per dish. To generate stably
expressing lines, cells were transfected as described above
and incubated for 2 days before being trypsinized, and
plated at 1:10 dilution in 10-cm dishes. Next day, antibiotic
selection was applied (2 mg/ml G418, Sigma) and cells were
re-fed with medium with fresh antibiotic every 3 days until
colonies were apparent (2–3 weeks).
Western blot analysis
Cells were washed twice with PBS and lysed in TNT
buffer (20 mM Tris–HCl, pH 7.5, 0.2 M NaCl, 1% Triton
100) supplemented immediately before use with protease
inhibitor cocktail tablets (Roche). Protein concentration
was determined by the bicinchoninic acid (BCA) method
using the BCA Protein Assay Reagent from Pierce. Pro-
teins (30 Ag) were subjected to sodium dodecyl sulfate
(SDS)–12% polyacrylamide gel electrophoresis, and then
electroblotted onto a nitrocellulose (Protran, Schleicher and
Schuell) membrane. After reacting with specific primary
antibodies (anti-caspase-3 or anti-actin), membranes were ex-
posed to horseradish peroxidase-conjugated secondary anti-
species (rabbit or mouse) antibody (Amersham), followed
by chemiluminescence (ECL, Amersham) detection by
autoradiography.
Analysis of apoptosis
(1) Detection of the 17-kDa fragment of caspase-3. The
cleavage of procaspase-3 (32 kDa) to the activated form
of 17-kDa was detected in cell extracts, obtained as
indicated above, by Western blot analysis revealed by
incubation with a 1/400th dilution of polyclonal
antibody specific for recombinant human caspase-3
(anti-caspase-3, Ab-4, NeoMarkers). Quantification of
protein bands was performed by densitometry (Image
Quant and TINA) in films developed after ECL
exposure.
(2) Biological activity of caspases. Cell extracts (aliquots
containing about 1 mg of protein per ml) were diluted
five times with assay buffer (25 mM HEPES, pH 7.5,
0.1% 3-((3-cholamidopropyl)-dimethylammonio)-1-
propanesulfonate (CHAPS), 10% sucrose, 10 mM
dithiothreitol, and 0.1 mg/ml ovoalbumin) and incubat-
ed at 37 jC for 2 h with a 10 mM concentration of
fluorescent substrate for specific (3, 6, or 8) caspases.
The reaction was stopped by addition of HPLC buffer
(H2O-acetonitrile 75/25, 0.1% trifluoroacetic acid). The
cleaved fluorescent substrate was determined by C18
reverse-phase high performance liquid chromatography
using fluorescent detection.
(3) Flow cytometry: (I) Annexin V-FITC staining can
identify apoptosis at earlier stages than assays based on
DNA fragmentation by recognition of cells undergoing
translocation of phosphatidylserine from the inner tothe outer side of the plasma membrane. We used the
Annexin V-FITC apoptosis detection kit I (BD
Pharmingen), which labels cells in conjunction with
the vital dye propidium iodide (PI), to distinguish
between early apoptosis (annexin+) and total death
(double-labeled cells). Cultures were stained according
to the manufacturer’s staining protocol, except that
cells were labeled in monolayer, then detached by
trypsinization and examined using a BD Biosciences
FACSCalibur flow cytometer. (II) DNA content
measurement was performed in cells suspended by
trypsinization, permeabilized with 70% ethanol, and
stained for 30 min at room temperature with PI (50 Ag/
ml in 0.3% Nonidet P40, 0.1% sodium citrate, and 20
Ag/ml RNase) before being analyzed by flow cytom-
etry. The percentage of total cell death was assigned
from the data observed in the hypodiploid range (M1
value) of the cell cycle, which corresponded to
apoptotic + necrotic cell population.
RT-PCR analysis of EP153R mRNA expression
Total RNA from transfected Vero or COS cell cultures
was isolated by using the Trizol reagent (Invitrogen) fol-
lowing the manufacturer’s recommendations. RNA was
reverse transcribed to single-stranded cDNA with the avian
myeloblastosis virus reverse transcriptase and oligo(dT)
primers from Promega. DNA was PCR-amplified with
Amplitaq DNA polymerase (Roche) and the following
primers: 5V-ATGTATTTTAAGAAAAAATACATCGG and
5V-TTATTTACCACAAATAAATAATAAATC and then an-
alyzed by electrophoresis on 0.7% agarose gels containing
ethidium bromide.
p53 transactivating activity
The p53RE-luc reporter plasmid contains 14 tandem
repeats of the p53 consensus binding motif (Stratagene).
Cell cultures (300000 cells) were transfected with p53RE-
luc plasmid (100 ng per 106 cells) and Lipofectamine
(Invitrogen) as described above, and incubated for 24 h.
After the indicated treatments, cell extracts in CCLR lysis
buffer (Luciferase Assay System, Promega) were obtained
and processed according to the manufacturer’s recommen-
dations. Light produced was measured and recorded in a
Monolight 2010 luminometer (Analytical Luminescence
Laboratory). Results were expressed as luminescence units
after normalization of protein concentration determined by
the BCA method.
Confocal microscopy
Vero cells were grown on coverslips to about 2  105
cells/cm2. Cultures were extensively rinsed (three times)
with PBS and fixed with cold 99.8% methanol for 15 min at
20 jC before rehydrating twice with PBS and blocking
C. Hurtado et al. / Virology 326 (2004) 160–170 169with 1% BSA in PBS (BSA/PBS) for 10 min at room
temperature. Cells were then incubated with specific prima-
ry antibodies against p53 (sc-6243, Santa Cruz Biotechno-
logies), diluted 1/20 in BSA/PBS for 2 h, and rinsed
extensively with PBS before the secondary antibody (Alexa
488 goat anti-rabbit, Molecular Probes) was added (diluted
1/500) for 1 h at room temperature in the dark. Finally, the
cells were rinsed successively with PBS, distilled water and
ethanol, and mounted with a drop of Mowiol on a pre-
cleaned microslide. Visualization of stained cultures was
performed in a Confocal Microradiance (BioRad) coupled to
a vertical Axioskop2 (Zeiss) microscope. Confocal images
were digitized, processed, and organized with Laser-
sharp2000 v.4, Adobe Photoshop 7.0 and Microsoft Power-
Point SP-2 software.Acknowledgments
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